Truist Reiterates Buy Rating on Sabra Healthcare (SBRA) Reflecting 2025 FFO Estimate Increase
Tweet Send to a Friend
Truist Securities analyst Michael Lewis reiterated a Buy rating and $18.00 price target on Sabra Healthcare REIT Inc. (NASDAQ: SBRA).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
